NVSN Stock Chart & Stats
$2671.00
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$2,067.01 - $3,009.59
Previous CloseN/A
VolumeN/A
Average Volume (3M)3.00
Market Cap
$4.91T
Enterprise Value$341.69K
Total Cash (Recent Filing)$7.69B
Total Debt (Recent Filing)$49.01B
Price to Earnings (P/E)23.7
Beta0.19
Next Earnings
Oct 27, 2026EPS Estimate
39.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.66
Shares Outstanding2,034,819,500
10 Day Avg. Volume4
30 Day Avg. Volume3
Financial Highlights & Ratios
PEG Ratio0.85
Price to Book (P/B)5.79
Price to Sales (P/S)4.88
P/FCF Ratio15.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$2,775.36Price Target Upside― Downside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)152.03
Revenue Forecast (FY)$988.24B
Bulls Say, Bears Say
Bulls Say
High Margins & Earnings QualitySustained high gross and operating margins coupled with large TTM free cash flow reflect durable pricing power and efficient operations. This margin profile supports consistent funding for R&D, commercialization, and shareholder returns, insulating core profitability over the medium term.
Strong Cash Generation & ReturnsRobust and repeatable free cash flow enables sizable dividends and buybacks while funding pipeline investment. Reliable cash generation enhances financial flexibility, supports capital allocation priorities and de-risks long-term strategy even amid cyclical pressures.
Priority-brand Momentum & PipelineRapid adoption of priority brands and multiple late-stage pipeline milestones expand addressable markets and offset legacy declines. Successful launches and regulatory progress create durable revenue streams and lifecycle extension opportunities, underpinning medium-term growth.
Bears Say
Rising LeverageMaterially higher leverage reduces financial flexibility and raises interest and refinancing sensitivity. With elevated debt relative to equity, the company is more exposed to earnings volatility and has less optionality for opportunistic M&A or cushioning of operational setbacks over the medium term.
Severe TTM Revenue DeclineA pronounced TTM revenue drop signals structural base effects from LOE/generic erosion or portfolio changes, creating a fragile near-term revenue foundation. Even with growth brands, such a large decline complicates forecasting, margin stability and investor confidence for several quarters.
Generic Erosion & Margin HeadwindsPersistent generic competition and acquisition-related gross-margin dilution can permanently compress margins and force higher promotional/R&D spend to defend share. These structural pressures can slow margin recovery and require sustained productivity gains to restore prior profitability levels.
NVSN FAQ
What was Novartis AG’s price range in the past 12 months?
Novartis AG lowest stock price was $2067.01 and its highest was $3009.59 in the past 12 months.
What is Novartis AG’s market cap?
Novartis AG’s market cap is $4.91T.
When is Novartis AG’s upcoming earnings report date?
Novartis AG’s upcoming earnings report date is Oct 27, 2026 which is in 95 days.
How were Novartis AG’s earnings last quarter?
Novartis AG released its earnings results on Jul 21, 2026. The company reported $42.196 earnings per share for the quarter, beating the consensus estimate of $38.029 by $4.167.
Is Novartis AG overvalued?
According to Wall Street analysts Novartis AG’s price is currently Undervalued.
Does Novartis AG pay dividends?
Novartis AG does not currently pay dividends.
What is Novartis AG’s EPS estimate?
Novartis AG’s EPS estimate is 39.27.
How many shares outstanding does Novartis AG have?
Novartis AG has 2,034,819,500 shares outstanding.
What happened to Novartis AG’s price movement after its last earnings report?
Novartis AG reported an EPS of $42.196 in its last earnings report, beating expectations of $38.029. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Novartis AG?
Currently, no hedge funds are holding shares in MX:NVSN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Novartis Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$2,775.36 (― Downside)
$2,775.36 (― Downside)
Blogger Sentiment
Bullish
MX:NVSN Sentiment 70%
Sector Average 66%
Sector Average 66%
News Sentiment
Very Bullish
Bullish news 93%
Bearish news 7%
Bearish news 7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.94%
12-Months-Change
Fundamentals
Return on Equity
3.24%
Trailing 12-Months
Asset Growth
16.90%
Trailing 12-Months
Company Description
Novartis AG
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
NVSN Stock 12 Month Forecast
Average Price Target
$2,775.36